These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14077815)

  • 1. CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS.
    RENNIE CS; ANDERSON DO
    Can Med Assoc J; 1963 Sep; 89(13):669-71. PubMed ID: 14077815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R; DALLECOSTE P
    Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
    [No Abstract]   [Full Text] [Related]  

  • 4. [ORAL THERAPY OF DIABETES MELLITUS].
    MOHNIKE G
    Cas Lek Cesk; 1964 Mar; 103():305-11. PubMed ID: 14138939
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
    Pereira VG; Wajchenberg BL; Shnaider J
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
    [No Abstract]   [Full Text] [Related]  

  • 6. "THE TOLBUTAMIDE TOLERANCE TEST, THE EFFECTS OF CHLOROTHIAZIDE ON GLUCOSE METABOLISM, AND THE PRESENT STATUS OF ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF DIABETES".
    MCDONALD WP
    Memphis Mid South Med J; 1963 Mar; 38():114-7. PubMed ID: 14087835
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with the oral antidiabetic compound, tolazamide.
    McKendry JB; Gfeller KF
    Can Med Assoc J; 1967 Mar; 96(9):531-5. PubMed ID: 6019353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.
    Moorhouse JA
    Can Med Assoc J; 1967 Mar; 96(9):536-9. PubMed ID: 6019354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CLINICAL EVALUATION OF A NEW HYPOGLYCEMIC AGENT WITH CHOLESTEROLEMIC ACTION (TOLAZAMIDE). PRELIMINARY REPORT].
    ROJAS L; COLINABRACHO L; DOMENGE L
    Rev Invest Clin; 1964; 16():173-82. PubMed ID: 14170236
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE INFLUENCE OF PLASMA UPON THE GLUCOSE UPTAKE OF ERYTHROCYTES IN VARIOUS DISEASES WITH GLYCOSURIA. 2. CHANGES IN THE INFLUENCE OF PLASMA UPON THE GLUCOSE UPTAKE OF ERYTHROCYTES IN TREATED DIABETES MELLITUS].
    YOSHIDA R
    Naika Hokan; 1963 Dec; 10():481-7. PubMed ID: 14100163
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute hypoglycemizing activity of intravenous tolazamide and tolbutamide: comparative study in normal, diabetic and hepatopathic man. Preliminary note].
    Milani R
    Minerva Med; 1965 Sep; 56(74):3163-5. PubMed ID: 5833700
    [No Abstract]   [Full Text] [Related]  

  • 12. [ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
    MARQUES M; RIETCORREA P
    Folia Endocrinol; 1964 Jun; 17():381-6. PubMed ID: 14210726
    [No Abstract]   [Full Text] [Related]  

  • 13. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
    SMITH DL; VECCHIO TJ; FORIST AA
    Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407
    [No Abstract]   [Full Text] [Related]  

  • 14. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLINICAL STUDY OF TOLAZAMIDE: A NEW ANTIDIABETIC SULFONYLUREA.
    STERN SB
    J La State Med Soc; 1965 Jun; 117():198-202. PubMed ID: 14292548
    [No Abstract]   [Full Text] [Related]  

  • 16. EVALUATION OF TOLAZAMIDE IN THE TREATMENT OF DIABETES MELLITUS.
    BRESSLER R; KATZ R
    Curr Ther Res Clin Exp; 1965 Apr; 7():219-25. PubMed ID: 14276012
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of chronic liver disease due to tolazamide.
    Nakao NL; Gelb AM; Stenger RJ; Siegel JH
    Gastroenterology; 1985 Jul; 89(1):192-5. PubMed ID: 4007403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolanase - a sulphonylurea antidiabetic agent.
    Drug Ther Bull; 1968 Mar; 6(7):27-8. PubMed ID: 5655488
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.